GlassScriptPhysician profile
Michael R Renfrow
NPI 1902068836
$1,710.88
in general payments reported to CMS, 2019-2025
12 companies · $671 in 2025
The $671 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $79.18 · 2021: $18.67 · 2022: $126 · 2023: $394 · 2024: $318 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $765.30 | 2019-2025 | Puraply Wound Matrix, Novachor, Simplimax |
| Conmed Corporation | $488.29 | 2023-2025 | Airseal |
| Intuitive Surgical, INC. | $125.13 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $121.87 | 2025 | |
| Abbvie INC. | $50.38 | 2022 | |
| Shire North American Group INC | $39.95 | 2019 | |
| Medtronic, INC. | $25.01 | 2023 | Venaseal |
| Kci USA, INC. | $22.89 | 2022 | |
| Hologic Sales and Service, LLC | $19.84 | 2023 | Coolseal Generator |
| Aroa Biosurgery Incorporated | $19.58 | 2024 | |
| Smith+Nephew, INC. | $18.32 | 2023 | Renasys Go V2 Home |
| Krystal Biotech INC | $14.32 | 2025 | Vyjuvek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Renfrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.